However, the number of subjects tested was considered relatively low, and further research with a larger sample size focusing on the ability of I-FABP to differentiate the severity levels in neonates with NEC is needed to confirm the findings of this study [36,37]. The gene discussed is FABP2; the disease is necrotizing enterocolitis.